Researcher
Katrijn Broos
- Keywords:Medicine
- Disciplines:Innate immunity, Cancer biology, Cancer therapy
Affiliations
- Faculty of Medicine and Pharmacy (Faculty)
Member
From7 Aug 2015 → 11 Oct 2019 - Basic (bio-) Medical Sciences (Department)
Member
From27 Oct 2014 → 31 Dec 2018 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 6 Oct 2019 - Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From1 Sep 2013 → 19 Mar 2021 - Physiology (Department)
Member
From1 Sep 2013 → 31 Dec 2013
Publications
1 - 10 of 16
- Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1+ Myeloid Dendritic Cells(2022)
Authors: Philipp Kalus, Jolien De Munck, Sarah Vanbellingen, Laura Carreer, Thessa Laeremans, Katrijn Broos, Inès Dufait, Julia Katharina Schwarze, Ivan Van Riet, Bart Neyns, et al.
- Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade(2021)
Authors: Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, M Verdonck, et al.
Pages: 172-182 - Anti-human PD-L1 Nanobody for Immuno-PET Imaging(2020)
Authors: Jessica Bridoux, Katrijn Broos, Quentin Lecocq, Pieterjan Debie, Charlotte Martin, Steven Ballet, Geert Raes, Sara Neyt, , Karine Breckpot, et al.
Pages: 1-15 - Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production(2019)
Authors: Katrijn Broos, Quentin Lecocq, Brenda De Keersmaecker, Geert Raes, Jurgen Corthals, Eva Lion, Kris Thielemans, Nick Devoogdt, Marleen Keyaerts, Karine Breckpot
Pages: E85-E85 - Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent(2019)
Authors: Katrijn Broos, Quentin Lecocq, Catarina Xavier, Jessica Bridoux, Tham Nguyen, Jurgen Corthals, Steve Schoonooghe, Eva Lion, Geert Raes, Marleen Keyaerts, et al.
- Evaluating single domain antibodies specific for PD-L1 as cancer nuclear imaging and therapy agents(2019)
Authors: Katrijn Broos
- Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety(2018)
Authors: Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, Carlo Heirman, Patrick Tjok Joe, Federico Perche, Sarah K Maenhout, Sanne Bevers, Katrijn Broos, Kim Deswarte, et al.
Pages: 9815-9829 - A versatile T cell-based assay to assess therapeutic antigenspecific PD-1-targeted approaches(2018)
Authors: Maarten Versteven, Johan M.J. Van den Bergh, Katrijn Broos, Fumihiro Fujiki, Diana Campillo-Davo, Hans De Reu, Soyoko Morimoto, Quentin Lecocq, Marleen Keyaerts, Zwi Berneman, et al.
Pages: 27797-27808 - Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy(2018)
Authors: Katrijn Broos, Quentin Lecocq, Geert Raes, Nick Devoogdt, Marleen Keyaerts, Karine Breckpot
Pages: 3559-3570 - Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation(2018)
Authors: Karel Fostier, Jo Caers, Nathalie Meuleman, Katrijn Broos, Jurgen Corthals, Kristiaan Thielemans, Rik Schots, Brenda De Keersmaecker
Pages: 20476-20489